Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline†
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline†
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-01-10
DOI
10.1016/j.annonc.2022.12.014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of venous thromboembolism in cancer patients: The dark side of the moon
- (2021) Cecilia Becattini et al. CANCER TREATMENT REVIEWS
- Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism
- (2021) Melina Verso et al. EUROPEAN JOURNAL OF CANCER
- Outcomes among patients with cancer and incidental or symptomatic venous thromboembolism: A systematic review and meta‐analysis
- (2021) Lucia Caiano et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial
- (2021) Jonathan G Moss et al. LANCET
- Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism
- (2021) Benjamin Planquette et al. CHEST
- Podoplanin promotes tumor growth, platelet aggregation, and venous thrombosis in murine models of ovarian cancer
- (2021) Tomoyuki Sasano et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Treatment of cancer‐associated venous thromboembolism: 12‐month outcomes of the placebo versus rivaroxaban randomization of the SELECT‐D Trial (SELECT‐D: 12m)
- (2020) Andrea Marshall et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Thrombosis in Patients with Myeloma Treated in the Myeloma IX and Myeloma XI Phase III Randomized Controlled Trials
- (2020) Charlotte Ann Bradbury et al. BLOOD
- Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis
- (2020) Frits I. Mulder et al. BLOOD
- Risk of venous thromboembolism associated with totally implantable venous access ports in cancer patients: a systematic review and meta-analysis
- (2020) Meng Jiang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
- (2020) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Latest advances in preventing thromboembolic disease in the ambulatory oncology patient
- (2020) Anthony Maraveyas THROMBOSIS RESEARCH
- Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis
- (2020) Holger J Schünemann et al. Lancet Haematology
- Venous thromboembolism in cancer patients: a population-based cohort study
- (2020) F. I. Mulder et al. BLOOD
- Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
- (2019) Alok A. Khorana et al. NEW ENGLAND JOURNAL OF MEDICINE
- The efficacy and safety of a catheter removal only strategy for the treatment of PICC line thrombosis versus standard of care anticoagulation: a retrospective review
- (2019) Joseph J. Shatzel et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants
- (2019) C Ay et al. ANNALS OF ONCOLOGY
- Updates on thrombotic events associated with multiple myeloma
- (2019) Despina Fotiou et al. Expert Review of Hematology
- Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug–Associated Thrombosis Among Patients With Multiple Myeloma
- (2019) Ang Li et al. Journal of the National Comprehensive Cancer Network
- Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score
- (2019) Kristen M. Sanfilippo et al. AMERICAN JOURNAL OF HEMATOLOGY
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
- (2019) Nigel S. Key et al. JOURNAL OF CLINICAL ONCOLOGY
- Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial
- (2019) Robert D. McBane et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Update from the laboratory: mechanistic studies of pathways of cancer-associated venous thrombosis using mouse models
- (2019) Yohei Hisada et al. Hematology-American Society of Hematology Education Program
- Caprini Risk Model Decreases Venous Thromboembolism Rates in Thoracic Surgery Cancer Patients
- (2018) Helene M. Sterbling et al. ANNALS OF THORACIC SURGERY
- Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
- (2018) Annie M. Young et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH
- (2018) A. A. Khorana et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer
- (2018) Gary H. Lyman et al. THROMBOSIS RESEARCH
- A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2)
- (2018) G.A. Davies et al. THROMBOSIS RESEARCH
- Antithrombotic medication in cancer-associated thrombocytopenia: current evidence and knowledge gaps
- (2018) A. Leader et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Extended thromboprophylaxis with low-molecular weight heparin (LMWH) following abdominopelvic cancer surgery
- (2018) Marc Carrier et al. AMERICAN JOURNAL OF SURGERY
- D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis
- (2018) Luis Jara-Palomares et al. BRITISH JOURNAL OF CANCER
- Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
- (2018) Marc Carrier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study
- (2018) Despina Fotiou et al. Blood Cancer Journal
- Application of risk factors for venous thromboembolism in patients with multiple myeloma starting chemotherapy, a real-world evaluation
- (2018) Hailey A. Baker et al. Cancer Medicine
- Epidemiology of first and recurrent venous thromboembolism in patients with active cancer
- (2017) Anja Katholing et al. THROMBOSIS AND HAEMOSTASIS
- Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study
- (2017) Luis Jara-Palomares et al. THROMBOSIS RESEARCH
- Epidemiology, diagnosis, prevention and treatment of catheter-related thrombosis in children and adults
- (2017) Lisa Baumann Kreuziger et al. THROMBOSIS RESEARCH
- Treatment of central venous catheter-associated deep venous thrombosis in cancer patients with rivaroxaban
- (2016) Eva S. Laube et al. AMERICAN JOURNAL OF HEMATOLOGY
- Timing of Chemical Thromboprophylaxis and Deep Vein Thrombosis in Major Colorectal Surgery
- (2016) Karen N. Zaghiyan et al. ANNALS OF SURGERY
- Preoperative Chemoprophylaxis Is Safe in Major Oncology Operations and Effective at Preventing Venous Thromboembolism
- (2016) Luke V. Selby et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Deep vein thrombosis and pulmonary embolism
- (2016) Marcello Di Nisio et al. LANCET
- Effect of serum monoclonal protein concentration on haemostasis in patients with multiple myeloma
- (2015) Heyu Huang et al. BLOOD COAGULATION & FIBRINOLYSIS
- Incidence of ultrasound-detected asymptomatic long-term central vein catheter-related thrombosis and fibrin sheath in cancer patients
- (2015) Maria Boddi et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Randomized controlled trial of enoxaparin versus intermittent pneumatic compression for venous thromboembolism prevention in Japanese surgical patients with gynecologic malignancy
- (2015) Chie Nagata et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study
- (2015) C. W. Francis et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Pattern of Frequent But Nontargeted Pharmacologic Thromboprophylaxis for Hospitalized Patients With Cancer at Academic Medical Centers: A Prospective, Cross-Sectional, Multicenter Study
- (2014) Jeffrey I. Zwicker et al. JOURNAL OF CLINICAL ONCOLOGY
- Optimal Duration of Low Molecular Weight Heparin for the Treatment of Cancer-Related Deep Vein Thrombosis: The Cancer-DACUS Study
- (2014) Mariasanta Napolitano et al. JOURNAL OF CLINICAL ONCOLOGY
- Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis
- (2014) G. J. Geersing et al. BMJ-British Medical Journal
- Lack of Evidence to Support Thromboprophylaxis in Hospitalized Medical Patients with Cancer
- (2013) Marc Carrier et al. AMERICAN JOURNAL OF MEDICINE
- A Randomized Study on 1-Week Versus 4-Week Prophylaxis for Venous Thromboembolism After Laparoscopic Surgery for Colorectal Cancer
- (2013) Maria Cristina Vedovati et al. ANNALS OF SURGERY
- Efficacy and safety profile of long-term exposure to lenalidomide in patients with recurrent multiple myeloma
- (2013) Guillemette Fouquet et al. CANCER
- Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography
- (2012) M. Marchetti et al. HAEMATOLOGICA
- Post-Discharge Venous Thromboembolism After Cancer Surgery
- (2011) Ryan P. Merkow et al. ANNALS OF SURGERY
- Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis
- (2011) M. CARRIER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Multiple Myeloma, Venous Thromboembolism, and Treatment-Related Risk of Thrombosis
- (2011) Elena Zamagni et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232)
- (2010) J. A. Zonder et al. BLOOD
- Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin
- (2010) Michela Cini et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
- (2010) S. BARBAR et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters
- (2010) Ha Tran et al. LEUKEMIA & LYMPHOMA
- Efficacy and safety of enoxaparin in Japanese patients undergoing curative abdominal or pelvic cancer surgery: Results from a multicenter, randomized, open-label study
- (2009) Masato Sakon et al. THROMBOSIS RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started